NASDAQ:HSCSW

Heart Test Laboratories - HSCSW Stock Forecast, Price & News

$0.17

-0.04 (-19.05%)

(As of 03/30/2023 12:28 PM ET)

Add

Compare

Today's Range: $0.15
▼
$0.28
50-Day Range: $0.06
▼
$0.42
52-Week Range: $0.06
▼
$1.75

Volume: 2,627 shs
Average Volume: 20,675 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Heart Test Laboratories (NASDAQ:HSCSW) Stock

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Receive HSCSW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heart Test Laboratories and its competitors with MarketBeat's FREE daily newsletter.

HSCSW Stock News Headlines

March 17, 2023 | finanznachrichten.de

Heart Test Laboratories, Inc.: HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results

March 16, 2023 | finance.yahoo.com

HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2023 Financial Results

March 30, 2023 | Investor Place Media (Ad)

The "King Of Quants" sees 10X potential...

Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...

March 6, 2023 | msn.com

Elite athletes with genetic heart disease can safely return to play with diagnosis and treatment, early study suggests

February 6, 2023 | finance.yahoo.com

HeartSciences Granted Key Israeli International Patent for its MyoVista® Wavelet Technology Utilizing Artificial Intelligence (AI) for Early Detection of Heart Disease

February 3, 2023 | finance.yahoo.com

HeartSciences Announces Further Internationalization of its Patent Portfolio

January 27, 2023 | seekingalpha.com

HSCS Heart Test Laboratories, Inc.

January 11, 2023 | msn.com

Desert Valley Hospital’s Cardiac Cath Lab unveils new GE imaging System

March 30, 2023 | Legacy Research (Affiliate) (Ad)

"Prepare for Five Years of Famine"

Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast

December 17, 2022 | markets.businessinsider.com

Maxim Group Keeps Their Buy Rating on Heart Test Laboratories, Inc. (HSCS)

December 16, 2022 | finance.yahoo.com

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2023 Financial Results

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive HSCSW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heart Test Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:HSCSW
CUSIP: N/A
CIK: 1468492
Web: heartsciences.com
Phone: 682-237-7781
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $9,299.00
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. Andrew Simpson (Age 53)
CEO, Pres & Chairman of Directors

Mr. Mark T. Hilz (Age 63)
COO, Sec. & Director
Comp: $104.17k

Ms. Danielle Watson (Age 40)
CFO & Treasurer

Key Competitors

View All Competitors

HSCSW Stock - Frequently Asked Questions

How have HSCSW shares performed in 2023?: Heart Test Laboratories' stock was trading at $0.2852 on January 1st, 2023. Since then, HSCSW stock has decreased by 26.4% and is now trading at $0.21.
View the best growth stocks for 2023 here.
What is Heart Test Laboratories' stock symbol?: Heart Test Laboratories trades on the NASDAQ under the ticker symbol "HSCSW."

How do I buy shares of Heart Test Laboratories?: Shares of HSCSW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Heart Test Laboratories' stock price today?: One share of HSCSW stock can currently be purchased for approximately $0.21.
How can I contact Heart Test Laboratories?: The official website for the company is heartsciences.com. The company can be reached via phone at 682-237-7781.

This page (NASDAQ:HSCSW) was last updated on 3/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial